Donald Trump requests PM Narendra Modi to supply hydroxychloroquine tablets to treat COVID-19 US patients

— Consider reading the article Donald Trump requests PM Narendra Modi to supply hydroxychloroquine tablets to treat COVID-19 US patients on OpIndia website —

US President Donald Trump on Saturday said that he has requested Prime Minister Narendra Modi to supply hydroxychloroquine tablets that can be used to treat the Chinese coronavirus patients. Reportedly, US President Trump announced at the White House Coronavirus task force briefing that he requested PM Narendra Modi for more Hydroxychloroquine tablets.

“After call today with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine,” he added.

President Trump also added that he too will take a tablet of hydroxychloroquine after announcing that he has requested Prime Minister during his telephonic conversation on Saturday to lift a hold on the US order of the medicine.

“India makes a lot of it. They need a lot too for their billion-plus people. The hydroxychloroquine, the anti-malaria drug will be released through the Strategic National Stockpile for treatment,” he said.

“I said I would appreciate if they would release the amounts that we ordered” of hydroxychloroquine, he said.

Hydroxychloroquine is in a class of drugs called antimalarials. It is used to prevent and treat acute attacks of malaria. The malaria drug hydroxychloroquine has been lately used to speed the recovery of patients who were mildly ill from the coronavirus.

— Consider reading the article Donald Trump requests PM Narendra Modi to supply hydroxychloroquine tablets to treat COVID-19 US patients on OpIndia website —

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to Drishtikone: Insightful Perspectives on Geopolitics and Culture.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.